Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
MONTREAL and CHARLOTTE, N.C.,
The H.C. Wainwright & Co. 22nd AnnualGlobal Investment Conference onTuesday, September 15, 2020 at11:30 a.m. Eastern Time - The Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on
Wednesday, September 23, 2020 at2:30 p.m. Eastern Time
A live webcast of the presentations can be accessed in the News & Events section of Milestone's website at www.milestonepharma.com. An archived replay of the webcasts will be available on the same website for approximately 30 days following the presentations.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone Pharmaceuticals operates in Canada and the
Contact
212-600-1902
david@argotpartners.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-upcoming-investor-conferences-301124643.html
SOURCE